Do you have a strong desire to improve quality of people’s life? Would you like to be part of team positioning Novo Nordisk as a leader in obesity care, and promoting Novo Nordisk’s product and services with strong customer obsession?
If your answer is yes, then this is your defining moment. Apply now and join the Novo Nordisk Czech Republic Obesity Sales organisation as our new Product Specialist, Obesity.
You will be based ideally in Prague. Territory to cover : Praha, Praha-Východ and additionally Ústí nad Labem, Děčín, Litoměřice, Česká Lípa, Mělník, Liberec, Mladá Boleslav, Nymburk, Jablonec nad Nisou, Smily).
Be part of the game-changing organisation!
As leader of your territory, you will be responsible for design, development and implementation of the business plan for your geographical area to ensure company objectives are achieved.
You will measure, track, analyse and present key metrics : prescription depth and breadth planning, reporting and effort analysis.
Your main responsibilities will include :
To be successful in this role, we expect you to have :
You are a self-starter, able to evaluate options and decide on your own with minimal supervision. You have proven leadership and decision-making ability.
You are demonstrating an aptitude for learning and ability to communicate technical and scientific product and disease management information, as well as value preposition for the product(s) under responsibility.
You have entrepreneurship mindset; you are strong influencer and an exceptional team player.
Your proactivity, accountability, and openness for challenges will be key to deliver on plans. As a person, you are a team player, energetic, passionate about living healthy and like to challenge status quo while focusing on solutions and opportunities.
You are comfortable taking initiative and have a strong personal drive and dedication.
About the Department
Novo Nordisk is a global healthcare company with more than 100 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people living with obesity, haemophilia, growth disorders and other serious chronic diseases.
Obesity therapy area is a fast-growing business unit in Novo Nordisk and makes the largest part of a future portfolio.
Headquartered in Denmark, Novo Nordisk employs over 47,000 people in 80 countries and markets its products in over 170 countries.
Czech affiliate has ambition to improve quality of patients’ life and bring innovation into the markets. In the Czech Republic, we employ 80 employees, and the office seat is in Prague.